285 related articles for article (PubMed ID: 34909670)
61. Drug Repurposing in Parkinson's Disease.
Athauda D; Foltynie T
CNS Drugs; 2018 Aug; 32(8):747-761. PubMed ID: 30066310
[TBL] [Abstract][Full Text] [Related]
62. The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis.
Müller A; Dickmanns A; Resch C; Schäkel K; Hailfinger S; Dobbelstein M; Schulze-Osthoff K; Kramer D
J Clin Invest; 2020 Nov; 130(11):5765-5781. PubMed ID: 32701505
[TBL] [Abstract][Full Text] [Related]
63. Drug Repurposing for Retinoblastoma: Recent Advances.
Dandu K; Kallamadi PR; Thakur SS; Rao CM
Curr Top Med Chem; 2019; 19(17):1535-1544. PubMed ID: 30659544
[TBL] [Abstract][Full Text] [Related]
64. Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis.
Tanigawa H; Miyata K; Tian Z; Aoi J; Kadomatsu T; Fukushima S; Ogata A; Takeda N; Zhao J; Zhu S; Terada K; Endo M; Morinaga J; Sugizaki T; Sato M; Morioka MS; Manabe I; Mashimo Y; Hata A; Taketomi Y; Yamamoto K; Murakami M; Araki K; Jinnin M; Ihn H; Oike Y
Sci Rep; 2016 Oct; 6():34690. PubMed ID: 27698489
[TBL] [Abstract][Full Text] [Related]
65. Drug repurposing for the treatment of staphylococcal infections.
Thangamani S; Mohammad H; Younis W; Seleem MN
Curr Pharm Des; 2015; 21(16):2089-100. PubMed ID: 25760334
[TBL] [Abstract][Full Text] [Related]
66. Computational drug repositioning for cancer therapeutics.
Jiao M; Liu G; Xue Y; Ding C
Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
[TBL] [Abstract][Full Text] [Related]
67. Drug repurposing in cancer.
Sleire L; Førde HE; Netland IA; Leiss L; Skeie BS; Enger PØ
Pharmacol Res; 2017 Oct; 124():74-91. PubMed ID: 28712971
[TBL] [Abstract][Full Text] [Related]
68. A new computational drug repurposing method using established disease-drug pair knowledge.
Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
[TBL] [Abstract][Full Text] [Related]
69. Efficacy and Safety of Systemic Treatments for Skin and Joint Manifestations in Patients With Psoriasis.
Abramovits W; Schlessinger J
J Drugs Dermatol; 2020 Mar; 19(3):306-313. PubMed ID: 32550687
[TBL] [Abstract][Full Text] [Related]
70. Repurposing existing products to accelerate injury recovery (REPAIR) of military relevant musculoskeletal conditions.
Clark AR; Mauntel TC; Goldman SM; Dearth CL
Front Bioeng Biotechnol; 2022; 10():1105599. PubMed ID: 36698630
[TBL] [Abstract][Full Text] [Related]
71. Repurposing of drugs for triple negative breast cancer: an overview.
Spini A; Donnini S; Pantziarka P; Crispino S; Ziche M
Ecancermedicalscience; 2020; 14():1071. PubMed ID: 32728387
[TBL] [Abstract][Full Text] [Related]
72. CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity.
Parsons CG
Neuropharmacology; 2019 Mar; 147():4-10. PubMed ID: 30165077
[TBL] [Abstract][Full Text] [Related]
73. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.
Lago SG; Bahn S
ACS Chem Neurosci; 2019 Jan; 10(1):58-78. PubMed ID: 29944339
[TBL] [Abstract][Full Text] [Related]
74. [Drug Repositioning for Alzheimer's Disease].
Ihara M; Saito S
Brain Nerve; 2019 Sep; 71(9):961-970. PubMed ID: 31506398
[TBL] [Abstract][Full Text] [Related]
75. Drug repurposing in cardiovascular diseases: Opportunity or hopeless dream?
Gelosa P; Castiglioni L; Camera M; Sironi L
Biochem Pharmacol; 2020 Jul; 177():113894. PubMed ID: 32142728
[TBL] [Abstract][Full Text] [Related]
76. Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs.
Olatunde A; Nigam M; Singh RK; Panwar AS; Lasisi A; Alhumaydhi FA; Jyoti Kumar V; Mishra AP; Sharifi-Rad J
Cancer Cell Int; 2021 Sep; 21(1):499. PubMed ID: 34535145
[TBL] [Abstract][Full Text] [Related]
77. An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA).
Lau QY; Tan YY; Goh VC; Lee DJ; Ng FM; Ong EH; Hill J; Chia CS
Antibiotics (Basel); 2015 Oct; 4(4):424-34. PubMed ID: 27025633
[TBL] [Abstract][Full Text] [Related]
78. Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.
Stenvang J; Kümler I; Nygård SB; Smith DH; Nielsen D; Brünner N; Moreira JM
Front Oncol; 2013 Dec; 3():313. PubMed ID: 24400218
[TBL] [Abstract][Full Text] [Related]
79. International regulatory and publicly-funded initiatives to advance drug repurposing.
Spin EL; Mantel-Teeuwisse AK; Pasmooij AMG
Front Med (Lausanne); 2024; 11():1387517. PubMed ID: 38882661
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
